(See below!) Consensus report on safe use of GLP-1 medications in T1D Despite the fact that GLP-1 receptor agonists (and dual GLP-1/GIP receptor agonists) are not FDA-approved for use in T1D for any indication, people with T1D are still able to access these drugs since they are approved to treat obesity and overweight
Among 142,349 participants with type 2 diabetes or obesity in the All of Us Research Program, we assessed co-occurrence across four SUD phenotypesAUD, CUD, OUD, and NUD
With the limited appetite of the patient- dietitian has to design a nutrient dense meal plan inorder to reduce the chances of nutrtional deficiencies or muscle loss
GLP-1 receptors exist throughout your digestive tract, your pancreas, and your brain
If you are struggling, a good place to start is by improving sleep and reducing cortisol-inducing stressors
Acetyl-L-carnitine in neuropathic pain: experimental data